Sommadossi Jean-Pierre
Atea Pharmaceuticals, Inc. · President
Sommadossi Jean-Pierre is listed in public filings as director, officer: President, CEO, and Chairman. This Sommadossi Jean-Pierre insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Atea Pharmaceuticals, Inc. (AVIR). Investors use Sommadossi Jean-Pierre's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0300k shares | Grant / ExerciseFeb 3, 2026 | $372.0K300k shares | $1.24 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.0M467.8k shares | Grant / ExerciseJan 31, 2026 | $449.8K106.1k shares | $4.24 | -- | |
| --99.5k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable99.5k shares | -- | -- | |
| --573.9k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable273k shares | -- | -- | |
| $1.3M440k shares | Grant / ExerciseJan 31, 2025 | $1.3M440k shares | $3.06 | -- | |
| $921k300.9k shares | Grant / ExerciseJan 31, 2025 | $271.1K88.6k shares | $3.06 | -- | |
| --99.5k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable99.5k shares | -- | -- | |
| --173.5k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable173.5k shares | -- | -- | |
| --389.5k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable99.5k shares | -- | -- | |
| $23M5.9M shares | SellSep 19, 2024 | $7.4K1.8k shares | $4.00 | -- | |
| $24M5.9M shares | SellSep 18, 2024 | $89.5K22.2k shares | $4.03 | -- | |
| $24M5.9M shares | SellSep 17, 2024 | $137.3K33.9k shares | $4.05 | -- |